PBAXU — Phoenix Biotech Acquisition Balance Sheet
0.000.00%
Last trade - 00:00- $68.56m
- $69.84m
- 21
- 48
- 51
- 34
Annual balance sheet for Phoenix Biotech Acquisition, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | 10-K | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Short Term Investments | 1.1 | 0.476 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 1.36 | 42.4 |
| Long Term Investments | ||
| Other Long Term Assets | ||
| Total Assets | 180 | 42.4 |
| Payable / Accrued | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 0.098 | 30.7 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 9.25 | 39.9 |
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Total Equity | 171 | 2.47 |
| Total Liabilities & Shareholders' Equity | 180 | 42.4 |
| Total Common Shares Outstanding |